Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
33129 | 129 | 23.0 | 59% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
350 | 3 | COMPLEMENT//MANNOSE BINDING LECTIN//IMMUNOLOGY | 35656 |
1655 | 2 | BIOSIMILAR//FCRN//PROTEIN FORMULATION | 6878 |
33129 | 1 | IND BIOCHEM PROGRAM//BETA METHYLNORLEUCINE//CX 397 | 129 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | IND BIOCHEM PROGRAM | address | 561079 | 6% | 30% | 8 |
2 | BETA METHYLNORLEUCINE | authKW | 473420 | 2% | 100% | 2 |
3 | CX 397 | authKW | 315612 | 2% | 67% | 2 |
4 | SEQUENCE VARIANT | authKW | 243463 | 5% | 17% | 6 |
5 | AMINO ACID ABBREVIATIONS | authKW | 236710 | 1% | 100% | 1 |
6 | AMINO ACID STRUCTURES | authKW | 236710 | 1% | 100% | 1 |
7 | ANALYT DEV NA | address | 236710 | 1% | 100% | 1 |
8 | AND REGRESSION ESTIMATION | authKW | 236710 | 1% | 100% | 1 |
9 | BIOCHIM MICROBIOL IMMUNOL | address | 236710 | 1% | 100% | 1 |
10 | BIOL PHARMA EARLY DEV | address | 236710 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biotechnology & Applied Microbiology | 1162 | 40% | 0% | 52 |
2 | Biochemical Research Methods | 314 | 17% | 0% | 22 |
3 | Pharmacology & Pharmacy | 163 | 22% | 0% | 29 |
4 | Chemistry, Analytical | 162 | 16% | 0% | 21 |
5 | Biochemistry & Molecular Biology | 161 | 32% | 0% | 41 |
6 | Education, Scientific Disciplines | 150 | 5% | 0% | 7 |
7 | Social Sciences, Interdisciplinary | 20 | 2% | 0% | 3 |
8 | Chemistry, Medicinal | 8 | 3% | 0% | 4 |
9 | Multidisciplinary Sciences | 7 | 2% | 0% | 2 |
10 | Biophysics | 7 | 4% | 0% | 5 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IND BIOCHEM PROGRAM | 561079 | 6% | 30% | 8 |
2 | ANALYT DEV NA | 236710 | 1% | 100% | 1 |
3 | BIOCHIM MICROBIOL IMMUNOL | 236710 | 1% | 100% | 1 |
4 | BIOL PHARMA EARLY DEV | 236710 | 1% | 100% | 1 |
5 | BIOPROC DEV NA | 236710 | 1% | 100% | 1 |
6 | DISCOVERY TECH GRP | 236710 | 1% | 100% | 1 |
7 | EARLY STAGE CELL CULTURE DEV | 236710 | 1% | 100% | 1 |
8 | METAB ENDOCRINE DRUG PROD DRUG EVALUAT | 236710 | 1% | 100% | 1 |
9 | NEW DRUG CHEM 2 | 236710 | 1% | 100% | 1 |
10 | PROC SCI ANALYT | 236710 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOPHARM INTERNATIONAL | 36643 | 7% | 2% | 9 |
2 | BIOCHEMICAL EDUCATION | 11548 | 4% | 1% | 5 |
3 | BIOPHARM-THE TECHNOLOGY & BUSINESS OF BIOPHARMACEUTICALS | 9464 | 2% | 2% | 2 |
4 | BIOPHARM INTERNATIONAL-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT | 8765 | 1% | 4% | 1 |
5 | MABS | 8030 | 4% | 1% | 5 |
6 | MICROBIAL CELL FACTORIES | 2797 | 3% | 0% | 4 |
7 | BIOLOGICALS | 2779 | 3% | 0% | 4 |
8 | BIO-TECHNOLOGY | 1483 | 2% | 0% | 3 |
9 | BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT | 1335 | 1% | 1% | 1 |
10 | PHARMACOPEIAL FORUM | 1136 | 1% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BETA METHYLNORLEUCINE | 473420 | 2% | 100% | 2 | Search BETA+METHYLNORLEUCINE | Search BETA+METHYLNORLEUCINE |
2 | CX 397 | 315612 | 2% | 67% | 2 | Search CX+397 | Search CX+397 |
3 | SEQUENCE VARIANT | 243463 | 5% | 17% | 6 | Search SEQUENCE+VARIANT | Search SEQUENCE+VARIANT |
4 | AMINO ACID ABBREVIATIONS | 236710 | 1% | 100% | 1 | Search AMINO+ACID+ABBREVIATIONS | Search AMINO+ACID+ABBREVIATIONS |
5 | AMINO ACID STRUCTURES | 236710 | 1% | 100% | 1 | Search AMINO+ACID+STRUCTURES | Search AMINO+ACID+STRUCTURES |
6 | AND REGRESSION ESTIMATION | 236710 | 1% | 100% | 1 | Search AND+REGRESSION+ESTIMATION | Search AND+REGRESSION+ESTIMATION |
7 | BIOPHARMACEUTICAL FERMENTATION | 236710 | 1% | 100% | 1 | Search BIOPHARMACEUTICAL+FERMENTATION | Search BIOPHARMACEUTICAL+FERMENTATION |
8 | BL21 DE3 | 236710 | 1% | 100% | 1 | Search BL21+DE3 | Search BL21+DE3 |
9 | CHEMICALLY DEFINED MEDIUM CDM | 236710 | 1% | 100% | 1 | Search CHEMICALLY+DEFINED+MEDIUM+CDM | Search CHEMICALLY+DEFINED+MEDIUM+CDM |
10 | EARLY STAGE CELL LINE DEVELOPMENT | 236710 | 1% | 100% | 1 | Search EARLY+STAGE+CELL+LINE+DEVELOPMENT | Search EARLY+STAGE+CELL+LINE+DEVELOPMENT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HARRIS, RP , KILBY, PM , (2014) AMINO ACID MISINCORPORATION IN RECOMBINANT BIOPHARMACEUTICAL PRODUCTS.CURRENT OPINION IN BIOTECHNOLOGY. VOL. 30. ISSUE . P. 45 -50 | 20 | 50% | 7 |
2 | NI, J , GAO, M , JAMES, A , YAO, JS , YUAN, T , CARPICK, B , D'AMORE, T , FARRELL, P , (2015) INVESTIGATION INTO THE MISINCORPORATION OF NORLEUCINE INTO A RECOMBINANT PROTEIN VACCINE CANDIDATE.JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY. VOL. 42. ISSUE 6. P. 971 -975 | 10 | 67% | 2 |
3 | HARRIS, RP , MATTOCKS, J , GREEN, PS , MOFFATT, F , KILBY, PM , (2012) DETERMINATION AND CONTROL OF LOW-LEVEL AMINO ACID MISINCORPORATION IN HUMAN THIOREDOXIN PROTEIN PRODUCED IN A RECOMBINANT ESCHERICHIA COLI PRODUCTION SYSTEM.BIOTECHNOLOGY AND BIOENGINEERING. VOL. 109. ISSUE 8. P. 1987-1995 | 10 | 71% | 2 |
4 | KHETAN, A , HUANG, YM , DOLNIKOVA, J , PEDERSON, NE , WEN, DY , YUSUF-MAKAGIANSAR, H , CHEN, P , RYLL, T , (2010) CONTROL OF MISINCORPORATION OF SERINE FOR ASPARAGINE DURING ANTIBODY PRODUCTION USING CHO CELLS.BIOTECHNOLOGY AND BIOENGINEERING. VOL. 107. ISSUE 1. P. 116-123 | 10 | 59% | 23 |
5 | ZHANG, S , BARTKOWIAK, L , NABISWA, B , MISHRA, P , FANN, J , OUELLETTE, D , CORREIA, I , REGIER, D , LIU, JJ , (2015) IDENTIFYING LOW-LEVEL SEQUENCE VARIANTS VIA NEXT GENERATION SEQUENCING TO AID STABLE CHO CELL LINE SCREENING.BIOTECHNOLOGY PROGRESS. VOL. 31. ISSUE 4. P. 1077 -1085 | 13 | 33% | 2 |
6 | BRADY, LJ , SCOTT, RA , BALLAND, A , (2015) AN OPTIMIZED APPROACH TO THE RAPID ASSESSMENT AND DETECTION OF SEQUENCE VARIANTS IN RECOMBINANT PROTEIN PRODUCTS.ANALYTICAL AND BIOANALYTICAL CHEMISTRY. VOL. 407. ISSUE 13. P. 3851 -3860 | 7 | 54% | 3 |
7 | SOINI, J , FALSCHLEHNER, C , LIEDERT, C , BERNHARDT, J , VUORISTO, J , NEUBAUER, P , (2008) NORVALINE IS ACCUMULATED AFTER A DOWN-SHIFT OF OXYGEN IN ESCHERICHIA COLI W3110.MICROBIAL CELL FACTORIES. VOL. 7. ISSUE . P. - | 10 | 43% | 25 |
8 | WALSH, G , (2013) MILESTONES AND MODERATE PROGRESS IN 2012 DRUG APPROVALS.BIOPHARM INTERNATIONAL. VOL. 26. ISSUE 4. P. 54-56 | 4 | 100% | 3 |
9 | LIAN, ZR , WU, QD , WANG, TT , (2016) IDENTIFICATION AND CHARACTERIZATION OF A -1 READING FRAMESHIFT IN THE HEAVY CHAIN CONSTANT REGION OF AN IGG1 RECOMBINANT MONOCLONAL ANTIBODY PRODUCED IN CHO CELLS.MABS. VOL. 8. ISSUE 2. P. 358 -370 | 13 | 28% | 0 |
10 | HE, LH , FRYE, C , (2016) A RISK-BASED GENETIC CHARACTERIZATION STRATEGY FOR RECOMBINANT CHO CELL LINES USED FOR CLINICAL AND COMMERCIAL APPLICATIONS.BIOPHARM INTERNATIONAL. VOL. 29. ISSUE 3. P. 32 -40 | 8 | 44% | 0 |
Classes with closest relation at Level 1 |